Daily Anesthesiology Research Analysis
Analyzed 91 papers and selected 3 impactful papers.
Summary
An updated Bayesian meta-analysis of 32 RCTs (n=27,687) shows selective digestive decontamination (SDD) probably reduces in-hospital mortality in mechanically ventilated ICU adults. A nationwide propensity-matched cohort of in-hospital cardiac arrest survivors associates targeted temperature management (TTM) with lower risk of certified new-onset brain disability. A prospective study in Anesthesiology finds reduced alpha/beta power on recovery-room EEG identifies a vulnerable brain phenotype linked to postoperative delirium.
Research Themes
- Critical care infection prevention and antimicrobial strategies
- Neuroprotection after in-hospital cardiac arrest
- Perioperative neurocognitive risk stratification using EEG
Selected Articles
1. Selective Decontamination of the Digestive Tract in Adult Mechanically Ventilated Patients - An Updated Systematic Review with Bayesian Meta-Analysis.
Across 32 RCTs (n=27,687), SDD in mechanically ventilated ICU adults was associated with lower in-hospital mortality (pooled RR 0.91; 95% CrI 0.82–0.99) using a Bayesian framework. These data strengthen the likelihood that SDD confers a survival benefit compared with usual care.
Impact: Large, contemporary synthesis of RCTs with Bayesian methods addresses persistent equipoise about SDD’s mortality effect and may inform guideline updates.
Clinical Implications: ICUs may consider SDD protocols for ventilated adults to reduce mortality, while balancing antimicrobial stewardship and local resistance ecology. Implementation should involve infection control oversight and surveillance for resistance.
Key Findings
- 32 RCTs (27,687 participants) were included; 30 trials contributed to hospital mortality.
- Bayesian meta-analysis estimated a pooled RR of in-hospital mortality of 0.91 (95% CrI 0.82–0.99) favoring SDD.
- Findings indicate a high probability that SDD reduces in-hospital death versus usual care/placebo.
Methodological Strengths
- Bayesian pooling of exclusively randomized trials with very large cumulative sample size.
- Focused primary outcome (hospital mortality) with contemporary trial inclusion.
Limitations
- Heterogeneity of SDD regimens and local microbiological contexts not detailed.
- Antimicrobial resistance and ecological impacts were not explicitly quantified.
Future Directions: Cluster-RCTs or stepped-wedge implementations incorporating resistance surveillance and cost-effectiveness, and subgroup analyses by ICU ecology to optimize SDD use.
BACKGROUND: There is uncertainty whether the use of selective decontamination of the digestive tract (SDD) as a preventive antimicrobial strategy reduces mortality in adult patients receiving mechanical ventilation in the intensive care unit (ICU). Following the publication of new data from a contemporary randomized clinical trial, an updated systematic review and meta-analysis was conducted to determine whether the use of SDD reduced hospital mortality compared to standard care. METHODS: An updated systematic review of a previously published meta-analysis was conducted including a search from September 12, 2022, to August 18, 2025, for randomized clinical trials (RCTs) of adults receiving mechanical ventilation in an ICU that compared SDD to standard care. Data were pooled using a Bayesian framework. The primary outcome was hospital mortality or closest approximation. RESULTS: One additional trial was identified, giving a total of 32 RCTs (27,687 participants), with 30 of the 32 RCTs (27,332 participants) contributing data to the primary outcome. The pooled estimated relative risk of hospital mortality for SDD compared to usual care or placebo was 0.91; 95% credible interval, 0.82 to 0.99, CONCLUSIONS: There is a high probability that in mechanically ventilated adults in the ICU, SDD, compared to standard care, is associated with a reduction in the risk of in-hospital death.
2. Association Between Targeted Temperature Management and New-Onset Brain Disability in in-Hospital Cardiac Arrest Survivors: A Nationwide Cohort Study.
In a nationwide PS-matched cohort of 31,592 IHCA survivors, TTM was associated with a lower hazard of certified new-onset brain disability (HR 0.85; 95% CI 0.75–0.96). The endpoint required specialist certification after ≥6 months of treatment, providing a rigorous measure of long-term neurological outcome.
Impact: Provides robust real-world evidence linking TTM to reduced long-term disability using a hard, registry-certified endpoint in a large national cohort.
Clinical Implications: Supports continued use and quality improvement of TTM protocols for IHCA survivors, emphasizing standardized temperature targets, duration, and neuroprognostication pathways.
Key Findings
- Propensity score-matched national cohort included 31,592 IHCA survivors (5,633 TTM vs 25,959 non-TTM).
- TTM was associated with reduced risk of new-onset brain disability (HR 0.85; 95% CI 0.75–0.96).
- Endpoint required specialist-certified, registry-based disability after ≥6 months of active treatment.
Methodological Strengths
- Large nationwide database with 1:5 propensity score matching and stratified Cox models.
- Hard neurological endpoint requiring specialist certification, reducing misclassification.
Limitations
- Retrospective observational design with potential residual confounding and protocol heterogeneity.
- Detailed TTM parameters (target temperature, duration, timing) and neurological exam data not reported.
Future Directions: Prospective, standardized TTM studies in IHCA focusing on temperature targets, timing, and duration, with patient-centered neurological outcomes and cost-effectiveness.
ObjectivesTargeted temperature management (TTM) is the standard of care for comatose cardiac arrest survivors. However, evidence regarding its long-term neurological impact specifically on in-hospital cardiac arrest (IHCA) survivors remains limited. This study investigated the association between TTM and the risk of new-onset brain disability in adult IHCA survivors using a "hard" endpoint derived from a national registry.DesignThis nationwide retrospective cohort study utilized the South Korean National Health Insurance Service database (2013-2022). Adult IHCA survivors were categorized into TTM and non-TTM groups. The primary endpoint was newly diagnosed brain disability registered in the Korea National Disability Registration System. This endpoint requires stringent certification by board-certified specialists after at least six months of active treatment to confirm irreversibility. We performed 1:5 propensity score matching and used stratified Cox proportional hazards models to estimate hazard ratios (HR).ResultsAmong 95 337 eligible survivors, 31 592 patients were included in the matched cohort (5633 TTM vs 25 959 non-TTM). The TTM group showed a significantly lower incidence of new-onset brain disability compared with the non-TTM group (5.0% vs 5.2%). In the PS-matched analysis, TTM was independently associated with a reduced risk of new-onset brain disability (HR, 0.85; 95% confidence interval [CI], 0.75-0.96;
3. Electroencephalographic Monitoring in the Recovery Room for Identification of Patients at Risk for Postoperative Delirium.
In 184 older adults, 31% developed POD. Recovery-room frontal EEG showed reduced alpha/beta power in POD versus NoPOD, with cumulative 10–20 Hz power discriminating risk (AUC 0.69). NoPOD patients exhibited augmentation of 8–20 Hz power from baseline, whereas POD patients did not.
Impact: Introduces a practical, postoperative EEG biomarker window in the PACU to identify patients at risk for delirium, enabling targeted prevention strategies.
Clinical Implications: Integrating brief frontal EEG monitoring in the PACU could inform targeted delirium prevention (e.g., non-pharmacologic bundles, analgesia optimization, sleep preservation) and postoperative resource allocation.
Key Findings
- Among 184 patients, 57 (31%) developed postoperative delirium.
- POD patients had significantly reduced alpha- and beta-band power; cumulative 10–20 Hz power best discriminated risk (AUC 0.69, 95% CI 0.60–0.77).
- NoPOD patients showed postoperative augmentation of 8–20 Hz power (peak ~16 Hz), whereas POD patients retained baseline-like spectra.
Methodological Strengths
- Prospective design with standardized POD screening in PACU and for five postoperative days.
- Multivariable regression of spectral-domain EEG features acquired during awake recovery.
Limitations
- Single-center observational study with moderate discrimination (AUC 0.69).
- External validity and device/processing generalizability require multicenter replication.
Future Directions: Develop pragmatic PACU EEG thresholds and integrate with clinical predictors to build intervention trials testing delirium prevention bundles in high-risk patients.
BACKGROUND: Electroencephalography (EEG), especially the assessment of alpha oscillations (8-12 Hz), has gained attention as a non-invasive marker of neural network integrity, with reduced alpha power linked to thalamocortical disconnectivity and increased vulnerability to postoperative delirium (POD) in elderly patients. Recent studies have demonstrated that altered EEG dynamics in the alpha-band frequencies during anesthesia emergence in the post-anesthesia care unit (PACU) are associated with POD. However, EEG data postoperatively from the recovery room are scarce. METHODS: This prospective observational study (2019-2022) at Charité-Universitätsmedizin Berlin investigates frontal EEG signatures and postoperative delirium (POD) in older adults undergoing surgery. Postoperative POD screening was performed in the recovery room and twice daily for five days. While the overall study collected pre- and intraoperative EEGs, we focus here on frontal EEG files recorded in the recovery room while patients were awake. Spectral-domain EEG features and monitor-derived indices were compared by multivariable regression analysis between those who developed POD and those who did not. RESULTS: A total of 184 patients had sufficient EEG data for analysis; 57 (31%) developed POD. Recovery-room recordings showed significantly reduced alpha- and beta-band power in POD vs NoPOD patients with cumulative 10-20 Hz power providing the best discrimination (AUC 0.69, 95% CI 0.60-0.77). NoPOD patients exhibited increases in alpha- and beta-band power (8-20 Hz) relative to preoperative baseline, with highest augmentation at approximately 16 Hz, whereas POD patients retained spectral patterns comparable to baseline across all frequency bands. CONCLUSIONS: These data suggest that frontal EEG monitoring in the recovery room can help identify a "vulnerable brain" phenotype associated with increased POD risk. Integrating this monitoring into postoperative care may support risk stratification and more individualized management.